Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK researchers develop hand-held skin scanning tool for heart disease screening

This article was originally published in Clinica

Executive Summary

A hand-held optical device that scans the skin for the early signs of heart disease and stroke could be available for sale within the next two years, according to the product's UK developers at Loughborough University (Leicestershire, UK). The noninvasive device, called PADD, uses an infrared light beam no more powerful than that used in a TV remote control to assess blood supply to the lower limb and foot and detect peripheral vascular disease (PVD). Poor blood supply to these extremities leads to tissue damage, ulceration, pain, loss of mobility, infection, gangrene and amputations. "If PVD is picked up early enough, many deaths could be prevented by better diet, exercise, drugs or surgery," explained Jody Brown, CEO of Dialog Devices, a Loughborough-based spin-out company set up to commercialise the device.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel